News

Phio Pharmaceuticals Corp. a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic…
Read More...

HitGen announced that it has entered into a drug discovery research collaboration with UPPTHERA Inc. to identify small molecule Hits against previous known-to-be undruggable targets and…
Read More...

Boehringer Ingelheim and Gubra announced a new research and licensing agreement focused on the identification and validation of targets and innovative peptide compounds for the…
Read More...

Partner Therapeutics, Inc. (PTx) announced top-line results of the investigator-led SARPAC (Sargramostim in Patients with Acute Hypoxic Respiratory Failure and Acute COVID-19) study of…
Read More...

Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, announced the signature of an exclusive license agreement with Merck KGaA, Darmstadt, Germany, a leading…
Read More...

Johnson & Johnson (the Company) announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine,…
Read More...

Welldoc, Inc., and Eli Lilly and Company announced a collaboration and licensing agreement to integrate Welldoc's software into Lilly's connected insulin solutions, currently in…
Read More...

Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, announced that the company has been chosen to…
Read More...

SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for rare cancer patients, announced a collaboration with the Mayo Clinic to advance research in…
Read More...

Xencor, Inc. a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, and UCLA…
Read More...

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and LYSA-LYSARC-CALYM announced that they have entered a strategic research collaboration to study valemetostat (DS-3201),…
Read More...

Seven Bridges, the industry-leading bioinformatics ecosystem provider, is supporting Pfizer Inc. in the development of a data management and collaboration solution for the…
Read More...

Altasciences is pleased to have contributed to the recent FDA approval of Vibegron, by performing three early phase clinical trials. Vibegron is a beta-3 adrenergic receptor (β3)…
Read More...

Crown Bioscience (CrownBio), JSR Life Sciences and Cambridge Quantum Computing (CQC) today announced a partnership agreement to explore the application of quantum technology to drive…
Read More...

QIAGEN and INOVIO Pharmaceuticals announced an extension of their partnership with a new master collaboration agreement to develop liquid biopsy-based companion* diagnostic products…
Read More...

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review the company’s Biologics License Application (BLA) for TicoVac, its tick-borne…
Read More...

Adaptive Biotechnologies Corporation a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and…
Read More...

UCB and Microsoft have announced a new multi-year, strategic collaboration to combine Microsoft's computational services, cloud, and artificial intelligence (AI) with UCB's drug…
Read More...

SIRION Biotech GmbH, a world leader in viral vector-based gene delivery technologies for gene & cell therapy, announced that it signed a license and collaboration agreement with…
Read More...

Compugen Ltd. a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced the expansion of its clinical collaboration agreement with Bristol…
Read More...